학술논문
Among adults with cardiovascular disease and BMI ≥ 27 kg/m2 but no diabetes, does semaglutide lower risk of cardiovascular mortality, myocardial infarction, or stroke when compared with placebo, and is it safe?
Document Type
Letter
Author
Source
In: Revue de Medecine Interne . (Revue de Medecine Interne, March 2024, 45(3):178-179)
Subject
Language
English
French
French
ISSN
17683122
02488663
02488663